Bausch & Lomb (BLCO) Cash from Financing Activities (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Cash from Financing Activities came in at $34.0 million in Q2 2026, down 62.22% YoY from $90.0 million in Q2 2025, and up 270.0% on a QoQ basis from -$20.0 million in Q1 2026.
Bausch & Lomb (BLCO) Cash from Financing Activities (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Cash from Financing Activities data on file, last reported at $34.0 million in Q2 2026.
- Quarterly Cash from Financing Activities fell 62.22% year-over-year to $34.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $118.0 million (down 52.23% YoY) and the FY2025 annual result came in at $225.0 million, up 26.4% from the prior year.
- Cash from Financing Activities grew to $34.0 million in Q2 2026, from -$20.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 billion in Q3 2023 to a low of -$109.0 million in Q3 2022.
- A 5-year average of $143.1 million and a median of $46.0 million in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities surged 1761.47% — and 2026, when it slumped 164.52%.
- Tracing BLCO's Cash from Financing Activities over 5 years: stood at -$7.0 million in 2022, then soared by 1328.57% to $86.0 million in 2023, then soared by 69.77% to $146.0 million in 2024, then fell by 20.55% to $116.0 million in 2025, then slumped by 70.69% to $34.0 million in 2026.
- The last three Cash from Financing Activities figures came in at $34.0 million (Q2 2026), -$20.0 million (Q1 2026), and $116.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 34.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.00 Mn |
| Jun 30, 2026 | 34.00 Mn |
| Mar 31, 2026 | -20.00 Mn |
| Mar 31, 2026 | -20.00 Mn |
| Dec 31, 2025 | 116.00 Mn |
| Dec 31, 2025 | 116.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | 90.00 Mn |
| Jun 30, 2025 | 90.00 Mn |
| Mar 31, 2025 | 31.00 Mn |
| Mar 31, 2025 | 31.00 Mn |
| Dec 31, 2024 | 146.00 Mn |
| Dec 31, 2024 | 146.00 Mn |
| Sep 30, 2024 | -20.00 Mn |
| Sep 30, 2024 | -20.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |